SonoSite Introduces the New BioZ Cardio Profile for Hemodynamic Monitoring in the Anesthesia Suite
14 October 2011 - 4:47AM
Business Wire
SonoSite, Inc. (Nasdaq:SONO), the world leader and
specialist in bedside and point-of-care ultrasound, today
introduced the new BioZ® Cardio Profile system with impedance
cardiography (ICG) technology for non-invasively monitoring a
patient’s hemodynamic profile in the hospital. Pioneered by NASA in
the 1960’s, ICG hemodynamic monitoring has traditionally been used
to treat patients with heart failure and hypertension, and it is
now ready to play a significant role in the anesthesia suite.
The BioZ Cardio Profile system offers a solution to one of the
biggest challenges for anesthesiologists- non-invasively
maintaining optimal intravascular (blood) volume during surgical
procedures. By integrating the BioZ Cardio Profile system into
surgical protocols, anesthesiologists will be able to impact
post-operative complications, length of hospital stay, and costs
associated with complications1. Furthermore, the BioZ provides a
complete solution for treating patients at the point-of-care.
Anesthesiologists can experience a demonstration of the BioZ Cardio
Profile at the American Society of Anesthesiologists meeting on
October 15-17th at the McCormick Place in Chicago.
The BioZ Cardio Profile Is One of the
First
In comparison to other hemodynamic measuring tools, the BioZ
product line with impedance cardiography technology is one of the
first completely non-invasive solutions for fluid management.
Traditionally, monitoring a patient’s hemodynamic profile required
extremely invasive methods, including pulmonary artery
catheterization. This type of catheter is typically placed in the
intensive care unit and must be threaded through two heart valves
and then placed into the pulmonary artery. With the high-risk
nature of placing a pulmonary artery catheter, patients are more
susceptible to infection, irregular heartbeats and rupture of the
pulmonary artery. These complications can thus result in patient
morbidity and mortality as well as increased hospital costs and
hospital length of stay1. In contrast, ICG measurements are easily
and safely obtained by simply placing skin sensors and reading the
measurements on the device.
A world class medical institution is currently assessing the
benefits of standardizing hemodynamic monitoring, including the
BioZ Cardio Profile, for surgical procedures in the anesthesia
suite. Gavin Martin, MB, CHB, Associate Professor of
Anesthesiology, Duke Medical Center said, “Being a part of a
hospital that is dedicated to providing the best in healthcare
delivery, we look for technology that can better patient care and
reduce complications. In assessing non-invasive cardiac output
monitors, we are discovering that real-time hemodynamic assessment
of our perioperative patients may lead to better post-surgical
outcomes.”
The BioZ Cardio Profile is an important tool designed to help
anesthesiologists successfully manage a patient’s fluid levels by
monitoring the patient’s stroke volume as fluids are administered.
As referenced in an article issued by the American Society of
Anesthesiologists, a potential complication caused from the
improper management of fluid, such as hypovolemia (decreased
intravascular volume), may be a “potential cause of organ
dysfunction, increased post-operative morbidity, and death.2”
The BioZ Cardio Profile can also be used for non-invasive
hemodynamic monitoring in the emergency department and in critical
care units, which may improve the treatment of heart failure and
sepsis patients.
For more information about the BioZ Cardio Profile, please click
here.
About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world
leader in bedside and point-of-care ultrasound and an industry
leader in ultra high-frequency micro-ultrasound technology and
impedance cardiography equipment. Headquartered near Seattle, the
company is represented by fourteen subsidiaries and a global
distribution network in over 100 countries. SonoSite’s small,
lightweight systems are expanding the use of ultrasound across the
clinical spectrum by cost-effectively bringing high-performance
ultrasound to the point of patient care.
1 Cannesson, Maxime, MD, PhD, and Patrice, MD Forget. "Fluid
Responsiveness Monitoring in Surgical and Critically Ill Patients."
Anesthesiology News (2010). Anesthesiology News. Web. .
2 Gan, Tong J., Andrew Soppitt, Mohamed Maroof, Habib El-Moalem,
Kerri M. Robertson, Eugene Moretti, Peter Dwane, and Peter S. A.
Glass. "Goal-directed Intraoperative Fluid Administration Reduces
Length of Hospital Stay after Major Surgery." American Society of
Anesthesiologists 97.4 (2002): 820-26. Print.
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2023 to Jul 2024